Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis d'ici le 30 septembre ?
Cas de rougeole aux États-Unis d'ici le 30 septembre ?
NOUVEAU
30 sept. 2026
2900+
97%
3000+
94%
$1,253 Vol.
2900+
$940 Vol.
97%
3000+
$313 Vol.
94%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Aug 24, 2026, 11:00 AM ET
Volume
$1,253Date de fin
30 sept. 2026Marché ouvert
Aug 24, 2026, 11:00 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$1,253Date de fin
30 sept. 2026Marché ouvert
Aug 24, 2026, 11:00 AM ETResolver
0x65070BE91...Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes